Andrew J. DSilva's most recent trade in OptimizeRx Corp was a trade of 1,432 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Sept. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.86 per share. | 01 Sep 2026 | 1,432 | 99,660 (0%) | 0% | 7.9 | 11,256 | Common Stock |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.71 per share. | 21 Aug 2026 | 1,243 | 43,492 (0%) | 0% | 7.7 | 9,584 | Common Stock |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2026 | 57,600 | 101,092 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | 19 Dec 2025 | 703 | 44,735 (0%) | 0% | 13.5 | 9,498 | Common Stock | |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | 11 Dec 2025 | 868 | 45,438 (0%) | 0% | 14.0 | 12,178 | Common Stock | |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | 01 Oct 2025 | 794 | 46,306 (0%) | 0% | 18.8 | 14,888 | Common Stock | |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | 01 Oct 2025 | 414 | 47,100 (0%) | 0% | 19.0 | 7,858 | Common Stock |